InformedDNA

InformedDNA specializes in genetics benefits management services, aiming to enhance healthcare spending and patient care through expert genomic insights. The company provides a robust platform that connects genetic counselors with patients, focusing on policy development, prior authorization for genetic testing, and payment integrity claims edits. InformedDNA offers utilization analytics and lab network strategies, empowering genetics experts to guide both patients and clinicians in effectively utilizing genetic information and novel gene-based treatments. With the largest independent team of board-certified genetics specialists in the United States, the company combines extensive clinical experience with advanced technology to deliver tailored solutions. InformedDNA is committed to optimizing clinical decisions, managing downstream costs, and improving health outcomes, ensuring that patients receive the highest quality of care through informed decision-making.

3 past transactions

Coriell Life Sciences

Acquisition in 2025
Coriell Life Sciences, Inc. is a Philadelphia-based company specializing in genetic laboratory interpretation and reporting services. Founded in 2013, it provides tools such as GeneDose, which offers medication risk management through drug-specific guidance and interpretation, and GeneDose LIVE, an advisory tool that considers genetics, demographics, lifestyles, and medical conditions. Additionally, the GeneDose Genetic Response Report details pharmacogenomic results and their clinical implications for individuals. Coriell also offers GeneVault and GeneExchange, which integrate genomic medicine into clinical care while managing genomic data. Their solutions cover various therapeutic areas, including pain management, cardiology, gastroenterology, neurology, psychiatry, anesthesiology, endocrinology, infectious diseases, oncology, and rheumatology. By bridging the gap between genetic knowledge and clinical application, Coriell Life Sciences aims to enhance medication safety and efficacy for healthcare providers and patients.

gWell

Acquisition in 2023
gWell's unique approach to combat the high cost and prevalence of Musculoskeletal care focuses on personalized care and prevention. Founded by physicians, our easy and secure genetic analysis zeros in on a person's inherited MSK risks and engages with a content-rich digital application, personalized to the user. When you learn more about what you might be at risk for, you can prevent new injuries or conditions from occurring and improve your overall health and wellness. Backed by science. HSA and FSA eligible.

Inherited Health

Acquisition in 2011
Inherited Health is an online health resource combining family health history and professional guidance to identify disease risk. The company makes it easy for consumers to safely and securely gather and store family health information and to get a personalized view of their hereditary disease risks. By providing individuals, their families, and their doctors, with the ability to access and share this critical information, Inherited Health helps everyone in the family take a proactive step in managing their health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.